Akebia Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
01.04.25
/
50%
€1.85
Target price
01.04.26
€5.54
Performance (%)
-36.32%
End price
02.04.26
€1.18
Summary
This prediction ended on 02.04.26 with a price of €1.18. Massive losses of -36.32% were the result for the BUY prediction by Jefferies_Financial_. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 6.689% | 6.689% | -21.934% |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten